Acumen Pharmaceuticals Price To Book vs. Net Income
| ABOS Stock | USD 2.70 0.02 0.74% |
For Acumen Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Acumen Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Acumen Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Acumen Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Acumen Pharmaceuticals over time as well as its relative position and ranking within its peers.
Check out Trending Equities. Is there potential for Biotechnology market expansion? Will Acumen introduce new products? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Acumen Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Acumen Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Acumen Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Acumen Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Acumen Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Acumen Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Acumen Pharmaceuticals Net Income vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Acumen Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Acumen Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Acumen Pharmaceuticals is rated below average in price to book category among its peers. It is rated below average in net income category among its peers . At this time, Acumen Pharmaceuticals' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Acumen Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Acumen Net Income vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Acumen Pharmaceuticals |
| = | 1.70 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Acumen Pharmaceuticals |
| = | (102.33 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Acumen Net Income Comparison
Acumen Pharmaceuticals is currently under evaluation in net income category among its peers.
Acumen Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Acumen Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Acumen Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Acumen Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Acumen Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -55.2 K | -58 K | |
| Net Interest Income | 11.8 M | 12.4 M | |
| Interest Income | 16.5 M | 17.3 M | |
| Operating Income | -102.6 M | -97.5 M | |
| Net Loss | -92.1 M | -87.5 M | |
| Income Before Tax | -92.1 M | -87.5 M | |
| Total Other Income Expense Net | 13.4 M | 14.1 M | |
| Net Loss | -38.6 M | -40.5 M | |
| Net Loss | -92.1 M | -87.5 M | |
| Income Tax Expense | -2.7 M | -2.6 M | |
| Non Operating Income Net Other | -12.7 K | -13.3 K | |
| Change To Netincome | 3.5 M | 3.3 M | |
| Net Loss | (1.96) | (2.06) | |
| Income Quality | 0.97 | 0.84 |
Acumen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Acumen Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Acumen Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Acumen Pharmaceuticals' important profitability drivers and their relationship over time.
Acumen Pharmaceuticals Earnings per Share Projection vs Actual
Use Acumen Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acumen Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Acumen Pharmaceuticals Pair Trading
Acumen Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Acumen Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acumen Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acumen Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acumen Pharmaceuticals to buy it.
The correlation of Acumen Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acumen Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acumen Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acumen Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Acumen Pharmaceuticals position
In addition to having Acumen Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Top Crypto Assets Thematic Idea Now
Top Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in null. The Top Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.